Key Developments: Cross Country Healthcare Inc (CCRN.O)
5.08USD
18 Jun 2013
$0.04 (+0.79%)
$5.04
$5.07
$5.13
$5.00
85,487
105,655
$6.23
$3.80
Latest Key Developments (Source: Significant Developments)
Cross Country Healthcare Inc Issues Q2 2013 Guidance Below Analysts' Estimates
Cross Country Healthcare Inc announced that for the second quarter of 2013, it expects revenue to be in the $110.0 million to $112.0 million range and loss per diluted share from continuing operations to be in the range of $0.01 to $0.03. According to I/B/E/S Estimates, analysts are expecting the Company to report revenue of $113 million and EPS of $0.01 for the second quarter of 2013. Full Article
Cross Country Healthcare Inc Issues Q1 2013 Mixed Guidance
Cross Country Healthcare Inc announced that for the first quarter of 2013, it expects revenue to be in the $110.0 million to $112.0 million range and earnings per diluted share (EPS) to be essentially at break-even. According to I/B/E/S Estimates, analysts are expecting the Company to report revenue of $126.7 million and EPS of $(0.01) for the first quarter of 2013. Full Article
Cross Country Healthcare Inc Announces Completion Of Sale Of Clinical Trial Services Business To ICON plc
Cross Country Healthcare Inc announced it has completed the previously announced sale of its clinical trial services business to ICON plc for $52 million, plus an earn-out of up to $3.75 million related to certain performance-based milestones. Cross Country Healthcare used a portion of the net proceeds from this transaction to repay all $29.3 million of its outstanding bank debt. Full Article
Cross Country Healthcare Inc Announces Agreement to Sell Clinical Trial Services Business to Icon PLC
Cross Country Healthcare Inc announced that it has entered into an agreement to sell its clinical trial services business to ICON plc for $52 million, plus an earn-out of up to $3.75 million related to certain performance-based milestones. This transaction is expected to be completed within the next 30 days. Cross Country Healthcare intends to use a portion of the net proceeds from this transaction to retire all of its outstanding bank debt. Full Article
Cross Country Healthcare Inc Issues Q4 2012 Guidance Below Analysts' Estimates
Cross Country Healthcare Inc announced that fourth quarter of 2012, it expects revenue to be in the $126.0-$129.0 million range and loss per diluted share to be in the range of $(0.01) to $(0.03). According to I/B/E/S Estimates, analysts are expecting the Company to report revenue of $130 million and EPS of $0.04 for fourth quarter of 2012. Full Article
Cross Country Healthcare, Inc. Issues Q3 2012 Guidance Below Analysts' Estimates
Cross Country Healthcare, Inc. announced that for the third quarter of 2012, it expects revenue to be in the range $126-$129 million and earnings per diluted share (EPS) to be in the range of $0.01-$0.03. According to I/B/E/S Estimates, analysts are expecting the Company to report revenue of $131 million and EPS of $0.06 for the third quarter of 2012. Full Article
Cross Country Healthcare, Inc. Issues Q2 2012 Guidance; EPS Guidance Below Analysts' Estimates
Cross Country Healthcare, Inc. announced that for the second quarter of 2012, it expects revenue to be in the range $128-$130 million and earnings per diluted share (EPS) to be in the range of $0.01-$0.03. According to I/B/E/S Estimates, analysts are expecting the Company to report revenue of $130 million and EPS of $0.05 for second quarter of 2012. Full Article
Cross Country Healthcare, Inc. Issues Q1 2012 Guidance below Analysts' Estimates
Cross Country Healthcare, Inc. announced that for the the first quarter of 2012, it expects revenue to be in the $126-$128 million range. Earnings per diluted share (EPS) to be in the range of $0.00 to $0.01. According to I/B/E/S Estimates, analysts are expecting the Company to report revenue of $129 million and EPS of $0.04 for the first quarter of 2012. Full Article
Cross Country Healthcare, Inc. Issues Q4 2011 Revenue And EPS Guidance Below Analysts' Estimates; Comments Q4 2011 EBITDA Guidance
Cross Country Healthcare, Inc. announced that for fourth quarter of 2011, it expects revenue to be in the range of $126-$128 million, adjusted EBITDA to be in the 4.5% to 5.0% and earnings per diluted share (EPS) to be in the range of $0.03-$0.05. According to I/B/E/S Estimates, analysts are expecting the Company to report revenue of $130 million, EBITDA of $6.4 million and EPS of $0.06. Full Article
Cross Country Healthcare, Inc. Issues Q3 2011 Guidance In Line With Analysts' Estimates; Comments On Q3 2011 EBITDA Guidance
Cross Country Healthcare, Inc. announced that for the third quarter of 2011, it expects revenue to be in the $128.0 million to $130.0 million range, adjusted EBITDA to be in the 4.5% to 5.0% range and earnings per diluted share (EPS) to be in the range of $0.03 to $0.05. According to I/B/E/S Estimates, analysts on an average were expecting the Company to report revenues of $128.0 million and EPS of $0.05 for the third quarter of 2011. Full Article
Earnings vs. 
Estimates
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
